Me considero una persona rutinaria. Tengo la tendencia natural de apegarme a las rutinas que funcionan, y me resulta difícil modificarlas una vez que se vuelven cómodas. Si bien las rutinas pueden ser útiles, en ocasiones hacen que la vida … Continue reading → Source:…
I am a creature of habit. I naturally stick to routines that work, and it is hard for me to change them once they feel comfortable. Routines can be helpful, but sometimes they make life feel automatic, like you are … Continue reading → Source:…
Lindsay Kelly shares her concern that MS cognitive symptoms are often overlooked. The post Taking MS brain symptoms seriously appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
Aranzazu Calzadu shares why speaking up about care expectations is essential to finding your ideal treatment approach. The post MS is your disease — own your care appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
Tweet This is a blast from the past. Many many years ago we got a call from someone with an interest in multiple sclerosis who had the idea that n-acetyl cysteine was a real treatment for MS and asked if we would do some work…
In multiple sclerosis (MS), mindfulness may increase the time a patient spends asleep while in bed, but physical activity appears to have small and inconsistent benefits on sleep. That’s according to a meta-analysis of five published studies that looked at the impact of interventions designed…
I would say that no one grows up telling themselves that they can’t wait to get their first minivan, but that’s probably just my opinion. I will allow for the possibility that some people have thought that exact thing, but I never did. As I…
A new formulation — a film that dissolves under the tongue — of cladribine for treating multiple sclerosis (MS) has moved closer to clinical testing, according to an update from its developer. Bionxt Solutions announced that it has completed manufacturing of a clinical-grade batch of…
Tweet News Multiple sclerosis: Could Roche’s bestselling drug Ocrevus be doing more harm than good in women with primary progressive MS? BMJ 2026; 393 doi: https://doi.org/10.1136/bmj.s666 (15 April 2026) Cite this as: BMJ 2026;393:s666 Neurological drugs have been in the media over the last couple of days. There is a report that…
Tweet This paper is perhaps interesting as we go into AAN week…All that will surface for the masses is the Conference abstract. For AAN they will all be published in the Journal Neurology, just as ECTRIMS abstracts are published in the Multiple Sclerosis Journal. The…